GST Reforms Hailed as 'a Decisive Win for Patients and Pharma Players'
Indian drug and medical device manufacturers have welcomed the GST reduction on medical devices and lifesaving drugs, calling it a major step toward improving access and easing treatment costs.
Venus Remedies | 04/09/2025 | By Dineshwori | 165
Venus Remedies Bags Exclusive Licensing Rights for MET-X from Infex Therapeutics
This strategic collaboration grants Venus Remedies the rights to spearhead clinical development, regulatory approvals, and commercialization of MET-X in India, focusing on its integration with meropenem to tackle infections resistant to conventional treatments.
Venus Remedies | 28/02/2025 | By Aishwarya | 214
Venus Remedies Secures GMP Certification for Antibiotic-Carbapenem Facility in Moldova
Venus Remedies has received GMP certification from the Ministry of Health of Moldova for its antibiotic-carbapenem manufacturing facility.
Venus Remedies | 04/01/2025 | By Abha | 213
Venus Remedies launches its flagship R&D drug Elores in Oman
Venus Remedies launches its flagship R&D drug Elores in Oman
Venus Remedies | 21/08/2023 | By Sudeep Soparkar | 483
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy